Not Signed In -
Bupropion Sustained-Release (Zyban) |
Buproban; Zyban |
Clinical Trial: Drug Treatment for Pathological Gambling
This study is currently recruiting patients.
|
Purpose
The purpose of the study is to determine whether the drug bupropion is an effective treatment for Pathological Gambling (PG).
| Condition | Treatment or Intervention |
|---|---|
| Gambling | Drug: Bupropion |
MedlinePlus related topics: Mental Health
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Bupropion Versus Placebo in the Treatment of Pathological Gambling
Expected Total Enrollment: 80
Study start: July 2002
As gambling opportunities proliferate, PG has become a major health concern. Despite its importance, few treatment options with proven efficacy exist. This study will attempt to identify an effective treatment for PG.
Participants are randomly assigned to receive either bupropion or placebo for 12 weeks. Participants are assessed at baseline and at Weeks 2, 3, 4, 5, 6, 8, 10, and 12. Self administered questionnaires and interviews are used to assess participants. Follow-up assessments are made 1, 3, and 6 months after study completion.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- PG for at least 1 year
Location and Contact Information
Iowa
Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, 52242, United States; Recruiting
Donald W. Black, MD 319-353-4431 donald-black@uiowa.edu
Donald W. Black, MD, Principal Investigator
More Information
Record last reviewed: November 2004
Last Updated: November 9, 2004
Record first received: February 28, 2003
ClinicalTrials.gov Identifier: NCT00055393
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Bupropion Sustained-Release (Zyban) (Drug Digest)
- Zyban (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
